Veritas Testing INC

Veritas Testing INC was paid $10.28M by Medicaid between Nov 2021 and Oct 2024, across 27 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 63% of everything it billed.

Compared with peers

Next to other Primary Care Clinic/Center providers in California

Rank by total paid#11 of 422

Median peer was paid$25K

This provider vs. median419×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2021	542	$13K
2022	166,107	$6.73M
2023	84,562	$3.54M
2024incomplete	609	$7K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	63%	92,734	36,462	$6.44M
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	15%	83,887	35,053	$1.55M
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	14%	29,718	16,349	$1.40M
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	8.3%	42,608	16,897	$852K
91320		<1%	129	117	$10K
0124A		<1%	383	383	$8K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	295	212	$8K
90480		<1%	148	134	$4K
90686		<1%	373	369	$4K
0004A		<1%	239	239	$3K
0134A		<1%	83	83	$2K
10005		<1%	19	19	$2K

15 more codes

0072A		<1%	129	$851.31
0071A		<1%	89	$683.89
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	120	$642.91
90715		<1%	76	$620.20
83655		<1%	87	$505.94
0081A		<1%	27	$339.00
G0008	Administration of influenza virus vaccine	<1%	411	$285.64
0073A		<1%	18	$283.91
0154A		<1%	25	$238.80
0053A		<1%	87	$89.42
90460	Immunization administration through 18 years of age via any route, first or only component	<1%	25	$78.30
85018		<1%	28	$22.77
90461		<1%	14	$9.00
99173		0%	32	$0.00
36416		0%	36	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGEORGIO, PETER (CHIEF MEDICAL OFFICER)

Parent organizationVERITAS TESTING INC